litlas
Log inCreate account

Peter M. Colman

Active 1972–2022

Also published as
PETER M. COLMAN
68
Papers
20,520
Citations
64
h-index
68
i10-index

Citations

Citations per year for Peter M. Colman1972: 10 citations1973: 8 citations1974: 21 citations1975: 14 citations1976: 28 citations1977: 27 citations1978: 20 citations1979: 25 citations1980: 25 citations1981: 33 citations1982: 22 citations1983: 25 citations1984: 24 citations1985: 26 citations1986: 30 citations1987: 31 citations1988: 57 citations1989: 63 citations1990: 42 citations1991: 50 citations1992: 74 citations1993: 79 citations1994: 118 citations1995: 120 citations1996: 95 citations1997: 132 citations1998: 131 citations1999: 109 citations2000: 129 citations2001: 102 citations2002: 110 citations2003: 121 citations2004: 120 citations2005: 139 citations2006: 203 citations2007: 218 citations2008: 245 citations2009: 240 citations2010: 250 citations2011: 221 citations2012: 204 citations2013: 266 citations2014: 207 citations2015: 195 citations2016: 171 citations2017: 209 citations2018: 146 citations2019: 416 citations2020: 427 citations2021: 401 citations2022: 253 citations2023: 179 citations2024: 253 citations2025: 128 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,259 citing papers, 32.7% of this breakdownUnited Kingdom: 641 citing papers, 9.3% of this breakdownAustralia: 478 citing papers, 6.9% of this breakdownGermany: 457 citing papers, 6.6% of this breakdownChina: 446 citing papers, 6.4% of this breakdownFrance: 292 citing papers, 4.2% of this breakdownJapan: 227 citing papers, 3.3% of this breakdownCanada: 190 citing papers, 2.7% of this breakdownItaly: 161 citing papers, 2.3% of this breakdownNetherlands: 153 citing papers, 2.2% of this breakdownSwitzerland: 136 citing papers, 2% of this breakdownIndia: 135 citing papers, 2% of this breakdown
0%32.7%Other 19.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology40.4%
  • Medicine37.8%
  • Immunology and Microbiology7.4%
  • Computer Science5.1%
  • Chemistry2.5%
  • Materials Science2.3%
  • Other4.5%

Topics

  • Cell death mechanisms and regulation5.4%
  • Monoclonal and Polyclonal Antibodies Research5.1%
  • Protein Structure and Dynamics4.4%
  • Influenza Virus Research Studies4.1%
  • Glycosylation and Glycoproteins Research3.6%
  • Computational Drug Discovery Methods2.9%
  • Other74.5%

Coauthors

All papers

Open in search
  1. Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations

    Authors: Richard W. Birkinshaw, Jianan Gong, Cindy S. Luo, Daisy Lio, Christine White, Mary Ann Anderson, Piers Blombery, Guillaume Lessène, Ian J. Majewski, Rachel Thijssen, Andrew W. Roberts, David C.S. Huang, Peter M. Colman, Peter E. Czabotar - Nature Communications 2019 cited by 244

  2. Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis

    Authors: Peter E. Czabotar, Dana Westphal, Grant Dewson, Stephen Ma, Colin Hockings, W. Douglas Fairlie, Erinna F. Lee, Shenggen Yao, A.Y. Robin, Brian J. Smith, David C.S. Huang, Ruth M. Kluck, Jerry M. Adams, Peter M. Colman - Cell 2013 cited by 580

  3. Rational design of potent sialidase-based inhibitors of influenza virus replication

    Authors: Mark von Itzstein, Wen‐Yang Wu, Gaik B. Kok, Michael S. Pegg, Jeffrey C. Dyason, Betty Jin, Tho van Phan, Mark L. Smythe, Hume F. White, Stuart W. Oliver, Peter M. Colman, Joseph Varghese, David Ryan, Jacqueline M. Woods, Richard C. Bethell, Vanessa J. Hotham, J. M. Cameron, Charles R. Penn - Nature 1993 cited by 1,864

  4. Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic Function

    Authors: Lin Chen, Simon N. Willis, Andrew H. Wei, Brian J. Smith, Jamie I. Fletcher, Mark G. Hinds, Peter M. Colman, Catherine L. Day, Jerry M. Adams, David C.S. Huang - Molecular Cell 2005 cited by 1,800

  5. The Dendritic Cell Receptor Clec9A Binds Damaged Cells via Exposed Actin Filaments

    Authors: Jian‐Guo Zhang, Peter E. Czabotar, Antonia N. Policheni, Irina Caminschi, Soo San Wan, Susie Kitsoulis, Kirsteen M. Tullett, A.Y. Robin, Rajini Brammananth, Mark F. van Delft, Jinhua Lu, Lorraine A. O’Reilly, Emma C. Josefsson, Benjamin T. Kile, Wei Jin Chin, Justine D. Mintern, Maya A. Olshina, Wilson Wong, Jake Baum, Mark D. Wright, David C.S. Huang, Narla Mohandas, Ross L. Coppel, Peter M. Colman, Nicos A. Nicola, Ken Shortman, Mireille H. Lahoud - Immunity 2012 cited by 332

  6. Shape Complementarity at Protein/Protein Interfaces

    Authors: Michael C. Lawrence, Peter M. Colman - Journal of Molecular Biology 1993 cited by 1,235

  7. Discovery of a Potent and Selective BCL-X L Inhibitor with in Vivo Activity

    Authors: Zhi‐Fu Tao, Lisa Hasvold, Le Wang, Xilu Wang, Andrew M. Petros, Chang H. Park, Erwin R. Boghaert, Nathaniel D. Catron, Jun Chen, Peter M. Colman, Peter E. Czabotar, Kurt Deshayes, Wayne J. Fairbrother, John A. Flygare, S.G. Hymowitz, Sha Jin, Russell A. Judge, Michael F. T. Koehler, Peter Kovar, Guillaume Lessène, Michael J. Mitten, Chudi Ndubaku, Paul Nimmer, Hans E. Purkey, Anatol Oleksijew, Darren C. Phillips, Brad E. Sleebs, Brian J. Smith, Morey L. Smith, Stephen K. Tahir, Keith G. Watson, Xiao Yu, John Xue, Haichao Zhang, Kerry Zobel, Saul H. Rosenberg, Chris Tse, Joel D. Leverson, Steven W. Elmore, Andrew J. Souers - ACS Medicinal Chemistry Letters 2014 cited by 331

  8. Structure-guided design of a selective BCL-XL inhibitor

    Authors: Guillaume Lessène, Peter E. Czabotar, Brad E. Sleebs, Kerry Zobel, Kym N. Lowes, Jerry M. Adams, Jonathan B. Baell, Peter M. Colman, Kurt Deshayes, Wayne J. Fairbrother, John A. Flygare, Paul Gibbons, Wilhelmus J. A. Kersten, Sanji Kulasegaram, Rebecca M. Moss, John P. Parisot, Brian J. Smith, Ian P. Street, Hong Yang, David C.S. Huang, Keith G. Watson - Nature Chemical Biology 2013 cited by 374

  9. Structural insights into the degradation of Mcl-1 induced by BH3 domains

    Authors: Peter E. Czabotar, Erinna F. Lee, Mark F. van Delft, Catherine L. Day, Brian J. Smith, David C.S. Huang, W. Douglas Fairlie, Mark G. Hinds, Peter M. Colman - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 441

  10. BCL-2 family antagonists for cancer therapy

    Authors: Guillaume Lessène, Peter E. Czabotar, Peter M. Colman - Nature Reviews Drug Discovery 2008 cited by 615

  11. EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

    Authors: Leah Fitzsimmons, Rachel Cartlidge, Catherine Chang, Nenad Sejic, Laura C.A. Galbraith, Chathura D. Suraweera, Deborah Croom‐Carter, Grant Dewson, Rosemary J. Tierney, Andrew Bell, C. Shannon‐Lowe, Marco J. Herold, Alan B. Rickinson, Peter M. Colman, David C.S. Huang, Andreas Strasser, Marc Kvansakul, Martin Rowe, Gemma L. Kelly - Cell Death and Differentiation 2019 cited by 63

  12. Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family

    Authors: Erinna F. Lee, Peter E. Czabotar, Brian J. Smith, Kurt Deshayes, Kerry Zobel, Peter M. Colman, W. Douglas Fairlie - Cell Death and Differentiation 2007 cited by 275

  13. To Trigger Apoptosis, Bak Exposes Its BH3 Domain and Homodimerizes via BH3:Groove Interactions

    Authors: Grant Dewson, Tobias Kratina, Huiyan W. Sim, Hamsa Puthalakath, Jerry M. Adams, Peter M. Colman, Ruth M. Kluck - Molecular Cell 2008 cited by 336

  14. Targeting BCL-2-like Proteins to Kill Cancer Cells

    Authors: Suzanne Cory, Andrew W. Roberts, Peter M. Colman, Jerry M. Adams - Trends in cancer 2016 cited by 149

  15. Bak Core and Latch Domains Separate during Activation, and Freed Core Domains Form Symmetric Homodimers

    Authors: Jason M. Brouwer, Dana Westphal, Grant Dewson, A.Y. Robin, Rachel T. Uren, Ray C. Bartolo, Geoff Thompson, Peter M. Colman, Ruth M. Kluck, Peter E. Czabotar - Molecular Cell 2014 cited by 158

  16. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands

    Authors: Marc Kvansakul, Hong Yang, W. Douglas Fairlie, Peter E. Czabotar, Silke Fischer, Matthew A. Perugini, David C.S. Huang, Peter M. Colman - Cell Death and Differentiation 2008 cited by 226

  17. Conformations of immunoglobulin hypervariable regions

    Authors: Cyrus Chothia, Arthur M. Lesk, Anna Tramontano, Michael Levitt, Sandra J. Smith‐Gill, Gillian M. Air, S. Sheriff, Eduardo A. Padlan, David R. Davies, W.R. Tulip, Peter M. Colman, Silvia Spinelli, Pedro M. Alzari, Roberto J. Poljak - Nature 1989 cited by 1,187

  18. The structural biology of type I viral membrane fusion

    Authors: Peter M. Colman, Michael C. Lawrence - Nature Reviews Molecular Cell Biology 2003 cited by 454

  19. BAK core dimers bind lipids and can be bridged by them

    Authors: Angus D. Cowan, Nicholas A. Smith, Jarrod J. Sandow, Eugene A. Kapp, Yepy H. Rustam, James M. Murphy, Jason M. Brouwer, Jonathan P. Bernardini, Michael J. Roy, Ahmad Z. Wardak, Iris K. L. Tan, Andrew I. Webb, Jacqueline M. Gulbis, Brian J. Smith, Gavin E. Reid, Grant Dewson, Peter M. Colman, Peter E. Czabotar - Nature Structural & Molecular Biology 2020 cited by 67

  20. A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosis

    Authors: Mark F. van Delft, Stéphane Chappaz, Yelena Khakham, Chinh T. Bui, Marlyse A. Debrincat, Kym N. Lowes, Jason M. Brouwer, Christoph Grohmann, Phillip P. Sharp, Laura F. Dagley, Lucy Li, Kate McArthur, Meng-Xiao Luo, Hui San Chin, W. Douglas Fairlie, Erinna F. Lee, David Segal, Stéphane Duflocq, Romina Lessene, Sabrina Bernard, Laure Peilleron, Thao Nguyen, Caroline S. Miles, Soo San Wan, Rachael M. Lane, Ahmad Z. Wardak, Kurt Lackovic, Peter M. Colman, Jarrod J. Sandow, Andrew I. Webb, Peter E. Czabotar, Grant Dewson, Keith G. Watson, David C.S. Huang, Guillaume Lessène, Benjamin T. Kile - Nature Chemical Biology 2019 cited by 50

  21. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution

    Authors: J.N. Varghese, W.G. Laver, Peter M. Colman - Nature 1983 cited by 898

  22. Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis

    Authors: Peter E. Czabotar, Erinna F. Lee, Geoff Thompson, Ahmad Z. Wardak, W. Douglas Fairlie, Peter M. Colman - Journal of Biological Chemistry 2011 cited by 121

  23. Crystallographic structure studies of an IgG molecule and an Fc fragment

    Authors: Robert Huber, J. Deisenhofer, Peter M. Colman, Masaaki Matsushima, Walter Palm - Nature 1976 cited by 421

  24. Electrostatic complementarity at protein/protein interfaces 1 1Edited by B. Honig

    Authors: Airlie J. McCoy, V. Chandana Epa, Peter M. Colman - Journal of Molecular Biology 1997 cited by 261